FDAnews
www.fdanews.com/articles/185690-paragonix-technologies-receives-ce-mark-for-two-cardiac-transport-devices
ParagonixTechnologies_Logo.png

Paragonix Technologies Receives CE Mark for Two Cardiac Transport Devices

February 20, 2018

Paragonix Technologies earned a CE Mark for its SherpaPak and SherpaPerfusion cardiac transport systems.

The SherpaPak is a single-use, disposable device for the hypothermic static preservation and transport of donor hearts.

The SherpaPerfusion system consists of a single-use, disposable device for hypothermic oxygenated perfusion preservation and transport of donor hearts.

Following the commercial launch of SherpaPak in the United States, the company plans to introduce the devices to transplant centers across Europe, said Paragonix President and COO Lisa Anderson.

View today's stories